Anaplastic lymphoma kinase inhibition in metastatic non-small cell lung cancer: clinical impact of alectinib

由 Muller, Ittai B, de Langen, Adrianus J, Giovannetti, Elisa, Peters, Godefridus J
發表在 Onco Targets Ther (2017)

Identification of Metabolic Biomarkers in Relation to Methotrexate Response in Early Rheumatoid Arthritis

由 Gosselt, Helen R., Muller, Ittai B., Jansen, Gerrit, van Weeghel, Michel, Vaz, Frédéric M., Hazes, Johanna M. W., Heil, Sandra G., de Jonge, Robert
發表在 J Pers Med (2020)

Computational comparison of common event-based differential splicing tools: practical considerations for laboratory researchers

由 Muller, Ittai B., Meijers, Stijn, Kampstra, Peter, van Dijk, Steven, van Elswijk, Michel, Lin, Marry, Wojtuszkiewicz, Anna M., Jansen, Gerrit, de Jonge, Robert, Cloos, Jacqueline
發表在 BMC Bioinformatics (2021)

Association of altered folylpolyglutamate synthetase pre-mRNA splicing with methotrexate unresponsiveness in early rheumatoid arthritis

由 Muller, Ittai B, Lin, Marry, Lems, Willem F, ter Wee, Marieke M, Wojtuszkiewicz, Anna, Nurmohamed, Michael T, Cloos, Jacqueline, Assaraf, Yehuda G, Jansen, Gerrit, de Jonge, Robert
發表在 Rheumatology (Oxford) (2020)

Validation of a Prognostic Multivariable Prediction Model for Insufficient Clinical Response to Methotrexate in Early Rheumatoid Arthritis and Its Clinical Application in Evidencio

由 Gosselt, Helen R., Verhoeven, Maxime M. A., de Rotte, Maurits C. F. J., Pluijm, Saskia M. F., Muller, Ittai B., Jansen, Gerrit, Tekstra, Janneke, Bulatović-Ćalasan, Maja, Heil, Sandra G., Lafeber, Floris P. J. G., Hazes, Johanna M. W., de Jonge, Robert
發表在 Rheumatol Ther (2020)